Friday 23 October 2026
Export CBRS’s income statement to Excel — free account
Cerebras Systems Inc.
CBRS Technology Semiconductors
109.37
8.61
−7.30%
Follow CBRS
| Older periods | Jun '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+1 more quarter Free account |
99.91 | — | 99.91 | 99.91 |
P/S ratio |
0.00 | — | 0.00 | 57.89 | |
P/FCF ratio |
0.00 | — | 0.00 | 0.00 | |
P/Operating CF |
1,583.87 | — | 1,583.87 | (557.71) | |
P/B ratio |
0.00 | — | 0.00 | 3.64 | |
Price to Tangible BV |
0.00 | — | 0.00 | 3.64 | |
EV/Sales |
0.00 | — | 0.00 | 44.97 | |
EV/EBITDA |
0.00 | — | 0.00 | 0.00 | |
EV/Operating CF |
0.00 | — | 0.00 | (151.28) | |
EV/FCF |
0.00 | — | 0.00 | (28.63) | |
Quick Ratio |
— | 1.93 | 2.33 | 5.57 | |
Current Ratio |
— | 2.15 | 2.51 | 5.82 | |
Net Debt/EBITDA |
0.00 | 0.00 | (367.82) | 18.22 | |
Debt/Assets |
0.00% | 15.24% | 27.31% | 9.98% | |
Debt/Equity |
— | 0.26 | 0.49 | 0.13 | |
Asset Turnover |
— | — | — | 0.10 | |
Operating CF/Net income |
(0.57) | — | (0.88) | 0.13 | |
Capex/Depreciation |
(16.07) | — | (6.52) | (6.07) | |
Research and Development Expense of Revenue |
58.81% | — | 39.03% | 177.75% | |
Selling, General and Administrative Expense of Revenue |
27.60% | — | 13.30% | 101.41% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
12.85% | — | 4.96% | 209.32% | |
Graham Net Nets |
0.07 | — | 0.07 | 0.20 | |
Graham Number |
0.00 | — | 0.00 | 54.94 | |
Earnings Yield |
1.00% | — | 1.00% | 1.00% | |
Free Cash Flow Yield |
0.00% | — | 0.00% | (2.71%) | |
Revenue per Share |
1.96 | — | 3.08 | 1.19 | |
Operating CF per Share |
(1.31) | — | 0.20 | (0.40) | |
Capex per Share |
(1.65) | — | (2.10) | (2.76) | |
Free Cash Flow per Share |
(2.95) | — | (1.90) | (3.16) | |
Cash per Share |
0.00 | 0.00 | 51.92 | 57.01 | |
Shareholders Equity per Share |
0.00 | 0.00 | 43.83 | 60.64 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.00 | 0.00 | 43.83 | 60.64 | |
Free Cash Flow |
(155.76) | — | (119.63) | (476.73) | |
Working Capital |
— | 824.11 | 2,153.72 | 7,555.63 | |
Capital Expenditures |
(86.85) | — | (131.97) | (416.90) | |
Net Current Asset Value |
— | 572.30 | 1,385.28 | 6,648.48 | |
EV/EBIT |
0.00 | — | 0.00 | 0.00 | |
Capex to Sales |
0.84 | — | 0.68 | 2.31 | |
Price to Operating Income |
0.00 | — | 0.00 | 0.00 | |
| Other line items | |||||
Average Assets |
— | — | — | 5,813.94 |
Columns are period end dates · fundamentals updated 2 Oct 2026